Intranasal Oxytocin Treatment Creates Long-Lasting Self-Sustaining Increases in Natural Oxytocin Levels in Autistic Men
Four weeks of intranasal oxytocin in men with ASD produced endogenous oxytocin increases that persisted 4 weeks after stopping, with larger increases in those showing greater social improvement.
Quick Facts
What This Study Found
Daily intranasal OT for 4 weeks increased endogenous salivary OT levels that persisted at 4-week follow-up. Increases were most pronounced in individuals with larger improvements in ASD social symptoms, suggesting a positive spiral of OT release.
Key Numbers
4-week double-blind RCT; endogenous salivary OT levels changed with treatment vs placebo.
How They Did This
Double-blind, randomized, placebo-controlled study. 34 adult men with ASD received 4 weeks of daily intranasal OT (24 IU) or placebo. Salivary OT measured before, after, and at 4-week and 1-year follow-up. Between-subject design.
Why This Research Matters
If oxytocin treatment can kick-start a self-sustaining cycle of increased natural oxytocin production — especially linked to social improvement — it suggests treatment could have lasting benefits beyond the treatment period, addressing a key concern about peptide therapy dependency.
The Bigger Picture
The concept of a 'positive spiral' — where exogenous oxytocin improves social behavior, which in turn triggers more natural oxytocin release — could fundamentally change how we think about peptide hormone therapy. Rather than lifelong supplementation, targeted treatment courses might produce self-sustaining benefits.
What This Study Doesn't Tell Us
Small sample size (34 participants). Only male adults with ASD studied. Saliva OT levels may not perfectly reflect brain OT activity. Mechanism of endogenous OT increase is inferred, not directly demonstrated.
Questions This Raises
- ?Does the positive spiral of endogenous OT increase translate to sustained behavioral improvements?
- ?Would this effect be seen in women with ASD or in children?
- ?Could combining OT treatment with social skills training amplify the positive feedback loop?
Trust & Context
- Key Stat:
- 4 weeks post-treatment endogenous oxytocin levels remained elevated after stopping intranasal OT administration
- Evidence Grade:
- Well-designed double-blind RCT with long-term follow-up. Small sample size limits power but the finding of persistent endogenous OT changes is novel and important.
- Study Age:
- Published in 2021. Longer-term oxytocin studies in ASD continue to explore the sustained effects concept.
- Original Title:
- Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.
- Published In:
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 43, 147-152 (2021)
- Authors:
- Alaerts, Kaat(5), Steyaert, Jean(2), Vanaudenaerde, Bart, Wenderoth, Nicole, Bernaerts, Sylvie
- Database ID:
- RPEP-05258
Evidence Hierarchy
Frequently Asked Questions
What is a positive spiral of oxytocin?
The idea that giving oxytocin improves social behavior, which creates positive social experiences, which naturally triggers more oxytocin release — creating a self-reinforcing cycle that continues even after stopping the medication.
Does this mean oxytocin treatment for autism could be temporary rather than permanent?
This study suggests yes — 4 weeks of treatment produced lasting changes in the body's own oxytocin system, particularly in those who showed social improvements. This could mean treatment courses rather than lifelong use.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05258APA
Alaerts, Kaat; Steyaert, Jean; Vanaudenaerde, Bart; Wenderoth, Nicole; Bernaerts, Sylvie. (2021). Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 43, 147-152. https://doi.org/10.1016/j.euroneuro.2020.11.014
MLA
Alaerts, Kaat, et al. "Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2021. https://doi.org/10.1016/j.euroneuro.2020.11.014
RethinkPeptides
RethinkPeptides Research Database. "Changes in endogenous oxytocin levels after intranasal oxyto..." RPEP-05258. Retrieved from https://rethinkpeptides.com/research/alaerts-2021-changes-in-endogenous-oxytocin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.